As of 12:32 PM on the 3rd, Alteogen is trading at 247,700 KRW, down 3.81% from the previous day. This represents a 97.84% increase compared to May 6. Alteogen is known as a biosimilar development company.
Over the past 5 days, individual investors have net purchased 70,780 shares, while foreigners and institutions have net sold 8,183 shares and 53,721 shares, respectively.
On June 1, Alteogen was a market topic for its "strong performance following the announcement of Phase 1 clinical trial results for a breast cancer treatment."
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
